What is the current Price Target for the Mbx Biosciences Inc stock?

The average Mbx Biosciences Inc target price is $89.76. This is 53.41% higher than the current stock price. The highest price target is 117.14%, the lowest is 20.83%. 12 Analysts have issued a price target Mbx Biosciences Inc 2027 .

How high will the Mbx Biosciences Inc stock rise?

No reliable answer can be given as to how high the Mbx Biosciences Inc stock will rise. The performance of stocks, including the Mbx Biosciences Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Mbx Biosciences Inc stock today?

The performance of Mbx Biosciences Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Mbx Biosciences Inc stock fall?

The decline in Mbx Biosciences Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Mbx Biosciences Inc Forecast, price target & analysts

$58.51

3.47%

Nasdaq, Oct 02, 04:28 pm EDT. Closed.

ISIN

US55287L1017

Symbol

MBX

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Analysts Charts Ownership News Strategies

Mbx Biosciences Inc Target price 2026 - Analyst rating & recommendation

Mbx Biosciences Inc Classifications & Recommendation

Buy

94%

Hold

Mbx Biosciences Inc Price Target

Target Price	$89.76
Price	$58.51
Potential	53.41% register free of charge
Number of Estimates	12

	12 Analysts have issued a price target Mbx Biosciences Inc 2027 . The average Mbx Biosciences Inc target price is $89.76. This is 53.41% register free of charge higher than the current stock price. The highest price target is $127.05 117.14% register free of charge , the lowest is $70.70 20.83% register free of charge .
	A rating was issued by 16 analysts: 15 Analysts recommend Mbx Biosciences Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Mbx Biosciences Inc stock has an average upside potential 2027 of 53.41% register free of charge . Most analysts recommend the Mbx Biosciences Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-2.38	-3.09
	59.11%	29.83%
P/E		negative

12 Analysts have issued a Mbx Biosciences Inc forecast for earnings per share. The average Mbx Biosciences Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-2.38	59.11%
2026	$-3.09 29.83% unlock
2027	$-4.03 30.42% unlock
2028	$-4.40 9.18% unlock
2029	$-3.98 9.55% unlock
2030	$-1.81 54.52% unlock
2031	$2.80 254.70% unlock
2032	$7.23 158.21% unlock
2033	$13.23 82.99% unlock

Current	-26.84	252.55%
2026	-18.92 29.51% unlock
2027	-14.52 23.26% unlock
2028	-13.30 8.40% unlock
2029	-14.69 10.45% unlock
2030	-32.40 120.56% unlock
2031	20.88 164.44% unlock
2032	8.09 61.25% unlock
2033	4.42 45.36% unlock

Mbx Biosciences Inc...

Current Mbx Biosciences Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
JP Morgan	Locked ➜ Locked	Locked	Aug 21 2026
Truist Securities	Locked ➜ Locked	Locked	Aug 10 2026
Mizuho	Locked ➜ Locked	Locked	Jul 29 2026
Barclays	Locked ➜ Locked	Locked	May 12 2026
Citizens	Locked ➜ Locked	Locked	May 12 2026
Truist Securities	Locked ➜ Locked	Locked	May 11 2026
Barclays	Locked ➜ Locked	Locked	Jan 28 2026

Analyst Rating	Date
Locked JP Morgan: Locked ➜ Locked	Aug 21 2026
Locked Truist Securities: Locked ➜ Locked	Aug 10 2026
Locked Mizuho: Locked ➜ Locked	Jul 29 2026
Locked Barclays: Locked ➜ Locked	May 12 2026
Locked Citizens: Locked ➜ Locked	May 12 2026
Locked Truist Securities: Locked ➜ Locked	May 11 2026
Locked Barclays: Locked ➜ Locked	Jan 28 2026

Discover more stocks with a high price target

NIO ADR 86.90%

Alibaba Group Holding Ltd 81.89%

Rheinmetall 70.55%

Tencent Holdings Ltd. 61.28%

Adyen 56.67%

Uber Technologies 51.26%

BYD 50.30%

Siemens Energy 43.79%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now